×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
Yahoo Finance
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD...
5 days ago
Spero Therapeutics to Participate in H.C. Wainwright Annual
GlobeNewswire
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical...
4 days ago
FY2024 EPS Estimates for Spero Therapeutics, Inc. Decreased by Analyst (NASDAQ:SPRO)
MarketBeat
Spero Therapeutics, Inc. (NASDAQ:SPRO - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 earnings estimates...
13 hours ago
HC Wainwright Brokers Boost Earnings Estimates for Spero Therapeutics, Inc. (NASDAQ:SPRO)
Defense World
Read HC Wainwright Brokers Boost Earnings Estimates for Spero Therapeutics, Inc. (NASDAQ:SPRO) at Defense World.
1 day ago
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value (NASDAQ:SPRO)
Seeking Alpha
Spero Therapeutics, Inc. has continued to build and advance its pipeline over the past several months and is now on the verge of generating...
1 month ago
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue Estimates
Yahoo News New Zealand
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -16.09% and 27.40%, respectively, for the quarter ended March...
1 day ago
FY2024 Earnings Estimate for Spero Therapeutics, Inc. (NASDAQ:SPRO) Issued By Cantor Fitzgerald
Defense World
Read FY2024 Earnings Estimate for Spero Therapeutics, Inc. (NASDAQ:SPRO) Issued By Cantor Fitzgerald at Defense World.
1 day ago
Spero Therapeutics, Inc. (NASDAQ:SPRO) Analysts Are Pretty Bullish On The Stock After Recent Results
Yahoo
Spero Therapeutics, Inc. (NASDAQ:SPRO) just released its latest third-quarter results and things are looking bullish...
17 hours ago
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
GlobeNewswire
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical...
2 months ago
Spero Therapeutics (NASDAQ:SPRO) Stock Rating Reaffirmed by HC Wainwright
Defense World
Read Spero Therapeutics (NASDAQ:SPRO) Stock Rating Reaffirmed by HC Wainwright at Defense World.
1 day ago